Website References

 

 

 

 

 

Kahn, C. R. (1978). Insulin resistance, insulin sensitivity, and insulin unresponsiveness: A necessary distinction. Metabol. 27, 1893-1902.

Kahn, C. R. (1994). Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43, 1066-1084.

Kahn, C. R. & Reynet, C. (1995). Identification of diabetes-related genes by subtraction cloning. In Molecular Biology of Diabetes, eds. Draznin, B. & LeRoith, D., Humana Press, Totowa.

Kahn, C. R., Warram, J. H., Krolewski, A. S., Takayama, S., & Soeldner, J. S. (1988). Insulin resistance and non-insulin-dependent diabetes mellitus. In Pathogenesis of non-insulin-dependent diabetes mellitus, eds. Grill, V. & Efendic, S., pp. 227-239. Raven, New York.

Kahn, S. E. (2001). Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J.Clin.Endocrinol.Metab 86, 4047-4058.

Kahn, S. E. (2003). The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46, 3-19.

Kakei, M., Kelly, R. P., Ashcroft, S. J., & Ashcroft, F. M. (1986). The ATP-sensitivity of K+ channels in rat pancreatic B-cells is modulated by ADP. FEBS Lett 208, 63-66.

Kaneto, H., Kajimoto, Y., Miyagawa, J., Matsuoka, T., Fujitani, Y., Umayahara, Y., Hanafusa, T., Matsuzawa, Y., Yamasaki, Y., & Hori, M. (1999). Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 48, 2398-2406.

Kang, G. X., Joseph, J. W., Chepurny, O. G., Monaco, M., Wheeler, M. B., Bos, J. L., Schwede, F., Genieser, H. G., & Holz, G. G. (2003). Epac-selective cAMP analog 8-pCPT-2 '-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ release and exocytosis in pancreatic beta-cells. Journal of Biological Chemistry 278, 8279-8285.

Katahira, H., Nagamatsu, S., Ozawa, S., Nakamichi, Y., Yamaguchi, S., Furukawa, H., Takizawa, M., Yoshimoto, K., Itagaki, E., & Ishida, H. (2001). Acute inhibition of proinsulin biosynthesis at the translational level by palmitic acid. Biochem Biophys.Res.Commun. 282, 507-510.

Kelly, L. J., Vicario, P. P., Thompson, G. M., Candelore, M. R., Doebber, T. W., Ventre, J., Wu, M. S., Meurer, R., Forrest, M. J., Conner, M. W., Cascieri, M. A., & Moller, D. E. (1998). Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. Endocrinology 139, 4920-4927.

Kennedy, E. D., Maechler, P., & Wollheim, C. B. (1998). Effects of depletion of mitochondrial DNA in metabolism secretion coupling in INS-1 cells. Diabetes 47, 374-380.

Khan, A., Ling, Z. C., & Landau, B. R. (1996). Quantifying the carboxylation of pyruvate in pancreatic islets. Journal of Biological Chemistry 271, 2539-2542.

Kilpatrick, E. D. & Robertson, R. P. (1998). Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell line. Diabetes 47, 606-611.

Kizaki, T., Suzuki, K., Hitomi, Y., Taniguchi, N., Saitoh, D., Watanabe, K., Onoe, K., Day, N. K., Good, R. A., & Ohno, H. (2002). Uncoupling protein 2 plays an important role in nitric oxide production of lipopolysaccharide-stimulated macrophages. Proc.Natl.Acad.Sci.U.S.A 99, 9392-9397.

Klein, R., Klein, B. E. K., & Moss, S. E. (1988). Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260, 2864-2871.

Klein, R., Klein, B. E. K., & Moss, S. E. (1996). Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Annals of Internal Medicine 124, 90-96.

Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., & Lehmann, J. M. (1997). Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc.Natl.Acad.Sci.U.S.A 94, 4318-4323.

Klingenberg, M. (1988). Nucleotide binding to uncoupling protein. Mechanism of control by protonation. Biochemistry 27, 781-791.

Klingenberg, M. & Appel, M. (1989). The uncoupling protein dimer can form a disulfide cross-link between the mobile C-terminal SH groups. Eur.J Biochem 180, 123-131.

Klingenberg, M. & Echtay, K. S. (2001). Uncoupling proteins: the issues from a biochemist point of view. Biochim.Biophys.Acta 1504, 128-143.

Klingenberg, M. & Huang, S. G. (1999). Structure and function of the uncoupling protein from brown adipose tissue. Biochim Biophys Acta 1415, 271-296.

Klingenberg, M. & Lin, C. S. (1986). Isolation and hydrodynamic characterization of the uncoupling protein from brown adipose tissue. Methods in Enzymology 126, 490-498.

Koehler, C. M., Jarosch, E., Tokatlidis, K., Schmid, K., Schweyen, R. J., & Schatz, G. (1998). Import of mitochondrial carriers mediated by essential proteins of the intermembrane space. Science 279, 369-373.

Kolterman, G., Gray, R. S., Griffin, J., Burstein, P., Inse, J., Scarlett, J., & Olefsky, J. M. (1981). Receptor and postreceptor defects contribute to the insulin resistance in non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 68, 957-969.

Korshunov, S. S., Skulachev, V. P., & Starkov, A. A. (1997). High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Letters 416, 15-18.

Korzeniewski, B. (1998). Regulation of ATP supply during muscle contraction: theoretical studies. Biochem J 330 ( Pt 3), 1189-1195.

Koshkin, V., Wang, X., Scherer, P. E., Chan, C. B., & Wheeler, M. B. (2003). Mitochondrial functional state in clonal pancreatic beta-cells exposed to free fatty acids. Journal of Biological Chemistry 278, 19709-19715.

Koskinen, P., Manttari, M., Manninen, V., Huttunen, J. K., Heinonen, O. P., & Frick, M. H. (1992). Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diab.Care. 15, 820-825.

Koyama, K., Chen, G., Lee, Y., & Unger, R. H. (1997). Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am.J Physiol 273, E708-E713.

Kramer, R. & Palmieri, F. (1989). Molecular aspects of isolated and reconstituted carrier proteins from animal mitochondria. Biochim.Biophys.Acta 974, 1-23.

Krauss, S., Zhang, C. Y., & Lowell, B. B. (2001). A significant portion of mitochondrial proton leak in intact thymocytes is dependent upon expression of UCP2. Proc Natl Acad Sci U.S.A in press.

Krauss, S., Zhang, C. Y., Scorrano, L., Dalgaard, L. T., St Pierre, J., Grey, S. T., & Lowell, B. B. (2003). Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J.Clin.Invest 112, 1831-1842.

Krippeit-Drews, P., Kramer, C., Welker, S., Lang, F., Ammon, H. P., & Drews, G. (1999). Interference of H2O2 with stimulus-secretion coupling in mouse pancreatic beta-cells. J.Physiol 514 ( Pt 2), 471-481.

Kruszynska, Y. T. & Olefsky, J. M. (1996). Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. J.Invest.Med. 44, 413-428.

Kubisch, H. M., Wang, J., Bray, T. M., & Phillips, J. P. (1997). Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic beta-cells against oxidative stress. Diabetes 46, 1563-1566.

Kumar, S., Boulton, A. J. M., Beck-Nielson, H., & et al. (1996). Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Diabetologia 39, 701-709.

Kwong, L. K. & Sohal, R. S. (1998). Substrate and site specificity of hydrogen peroxide generation in mouse mitochondria. Arch.Biochem Biophys. 350, 118-126.

Lacy, P. E. & Kostianovsky, M. (1967). Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16, 35-39.

Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. (1991). Simplified mammalian DNA isolation procedure. Nucleic Acids Res 19, 4293.

Laloi, M., Klein, M., Riesmeier, J. W., Muller-Rober, B., Fleury, C., Bouillaud, F., & Ricquier, D. (1997). A plant cold-induced uncoupling protein. Nature 389, 135-136.

Lameloise, N., Muzzin, P., Prentki, M., & Assimacopoulos-Jeannet, F. (2001). Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion? Diabetes 50, 803-809.

Land, S. C., Porterfield, D. M., Sanger, R. H., & Smith, P. J. (1999). The self-referencing oxygen-selective microelectrode: detection of transmembrane oxygen flux from single cells. J.Exp.Biol. 202 ( Pt 2), 211-218.

Lardy, H. A. & Wellman, H. (1952). Oxidative phosphorylations: role of inorganic phosphate and acceptor systems in control of metabolic rates. J Biol Chem 195, 215-224.

Larrouy, D., Laharrague, P., Carrera, G., Viguerie-Bascands, N., Levi-Meyrueis, C., Fleury, C., Pecqueur, C., Nibbelink, M., Andre, M., Casteilla, L., & Ricquier, D. (1997). Kupffer cells are a dominant site of uncoupling protein 2 expression in rat liver. Biochemical and Biophysical Research Communications 235, 760-764.

Le Fur, S., Le Stunff, C., Dos, S. C., & Bougneres, P. (2004). The common -866 G/A polymorphism in the promoter of uncoupling protein 2 is associated with increased carbohydrate and decreased lipid oxidation in juvenile obesity. Diabetes 53, 235-239.

Leahy, J. L., Bonner-Weir, S., & Weir, G. C. (1992). B-cell dysfunction induced by chronic hyperglycemia. Diabetes Care 15, 442-455.

Lebovitz, H. E. (1995). Sulfonylurea drugs. In Therapy for diabetes and related disorders, ed. Lebovitz, H. E., pp. 116-123. American Diabetes Association, Alexandria.

Lee, H. C., Kim, S. J., Kim, K. S., Shin, H. C., & Yoon, J. W. (2000). Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature 408, 483-488.

Lee, Y., Hirose, H., Zhou, Y. T., Esser, V., McGarry, J. D., & Unger, R. H. (1997). Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes 46, 408-413.

Lenzen, S., Drinkgern, J., & Tiedge, M. (1996). Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic.Biol Med 20, 463-466.

Li, L. X., Skorpen, F., Egeberg, K., Jorgensen, I. H., & Grill, V. (2002). Induction of uncoupling protein 2 mRNA in beta-cells is stimulated by oxidation of fatty acids but not by nutrient oversupply. Endocrinology 143, 1371-1377.

Light, P. E., Manning Fox, J. E., Riedel, M. J., & Wheeler, M. B. (2002). Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism. Mol.Endocrinol. 16, 2135-2144.

Lin, C. S., Hackenberg, H., & Klingenberg, E. M. (1980). The uncoupling protein from brown adipose tissue mitochondria is a dimer. A hydrodynamic study. FEBS Letters 113, 304-306.

Lin, C. S. & Klingenberg, M. (1982). Characteristics of the isolated purine nucleotide binding protein from brown fat mitochondria. Biochemistry 21, 2950-2956.

Litsky, M. L. & Pfeiffer, D. R. (1997). Regulation of the mitochondrial Ca2+ uniporter by external adenine nucleotides: the uniporter behaves like a gated channel which is regulated by nucleotides and divalent cations. Biochemistry 36, 7071-7080.

Liu, Q., Bai, C., Chen, F., Wang, R., MacDonald, T., Gu, M., Zhang, Q., Morsy, M. A., & Caskey, C. T. (1998). Uncoupling protein-3: a muscle-specific gene upregulated by leptin in ob/ob mice. Gene 207, 1-7.

Longo, E. A., Tornheim, K., Deeney, J. T., Varnum, B. A., Tillotson, D., Prentki, M., & Corkey, B. E. (1991). Oscillations in cytosolic free Ca2+, oxygen consumption,  and insulin secretion in glucose-stimulated rat pancreatic islets. J Biol Chem 266, 9314-9319.

Lowell, B. B. & Spiegelman, B. M. (2000). Towards a molecular understanding of adaptive thermogenesis. Nature 404, 652-660.

Lu, D., Mulder, H., Zhao, P., Burgess, S. C., Jensen, M. V., Kamzolova, S., Newgard, C. B., & Sherry, A. D. (2002). 13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS). Proc.Natl.Acad.Sci.U.S.A 99, 2708-2713.

Ludwig, D. S. (2002). The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 287, 2414-2423.

MacDonald, M. J. (1982). Evidence for the malate aspartate shuttle in pancreatic islets. Arch Biochem Biophys 213, 643-649.

MacDonald, M. J. (1990). Elusive proximal signals of beta-cells for insulin secretion. Diabetes 39, 1461-1466.

MacDonald, M. J. (1995). Feasibility of a mitochondrial pyruvate malate shuttle in pancreatic islets. Further implication of cytosolic NADPH in insulin secretion. Journal of Biological Chemistry 270, 20051-20058.

MacDonald, P. E., Salapatek, A. M., & Wheeler, M. B. (2003). Temperature and redox state dependence of native Kv2.1 currents in rat pancreatic beta-cells. J.Physiol 546, 647-653.

Mackler, J. M., Drummond, J. A., Loewen, C. A., Robinson, I. M., & Reist, N. E. (2002). The C(2)B Ca(2+)-binding motif of synaptotagmin is required for synaptic transmission in vivo. Nature 418, 340-344.

Maechler, P., Jornot, L., & Wollheim, C. B. (1999). Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells. Journal of Biological Chemistry 274, 27905-27913.

Maechler, P., Kennedy, E. D., Pozzan, T., & Wollheim, C. B. (1997). Mitochondrial activation directly triggers the exocytosis of insulin in permeabilized pancreatic beta-cells. EMBO J 16, 3833-3841.

Maechler, P., Kennedy, E. D., Wang, H., & Wollheim, C. B. (1998). Desensitization of mitochondrial Ca2+ and insulin secretion responses in the beta cell. J Biol Chem 273, 20770-20778.

Maechler, P. & Wollheim, C. B. (1999). Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature 402, 685-689.

Maechler, P. & Wollheim, C. B. (2001). Mitochondrial function in normal and diabetic beta-cells. Nature 414, 807-812.

Malaisse, W. J., Hutton, J. C., Kawazu, S., Herchuelz, A., Valverde, I., & Sener, A. (1979a). The stimulus-secretion coupling of glucose-induced insulin release. XXXV. The links between metabolic and cationic events. Diabetologia 16, 331-341.

Malaisse, W. J., Sener, A., Herchuelz, A., & Hutton, J. C. (1979b). Insulin release: the fuel hypothesis. Metabolism 28, 373-386.

Mao, W., Yu, X. X., Zhong, A., Li, W., Brush, J., Sherwood, S. W., Adams, S. H., & Pan, G. (1999). UCP4, a novel brain-specific mitochondrial protein that reduces membrane potential in mammalian cells. FEBS Letters 443, 326-330.

Mariot, P., Gilon, P., Nenquin, M., & Henquin, J. C. (1998). Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in beta-cells. Diabetes 47, 365-373.

Marshak, S., Leibowitz, G., Bertuzzi, F., Socci, C., Kaiser, N., Gross, D. J., Cerasi, E., & Melloul, D. (1999). Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes 48, 1230-1236.

Marx, J. (2002). Unraveling the causes of diabetes. Science 296, 686-689.

Marzban, L., Park, K., & Verchere, C. B. (2003). Islet amyloid polypeptide and type 2 diabetes. Exp.Gerontol. 38, 347-351.

Matschinsky, F. M. (1996). A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm (Banting Lecture 1995). Diabetes 45, 223-241.

Matsuda, J., Hosoda, K., Itoh, H., Son, C., Doi, K., Hanaoka, I., Inoue, G., Nishimura, H., Yoshimasa, Y., Yamori, Y., Odaka, H., & Nakao, K. (1998). Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes. Diabetes 47, 1809-1814.

Matthews, E. K. & Sakamoto, Y. (1975). Electrical characteristics of pancreatic islet cells. J.Physiol 246, 421-437.

Maycox, P. R., Deckwerth, T., Hell, J. W., & Jahn, R. (1988). Glutamate uptake by brain synaptic vesicles. Energy dependence of transport and functional reconstitution in proteoliposomes. J Biol Chem 263, 15423-15428.

McGarry, J. D. (2002). Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51, 7-18.

McGarry, J. D. & Dobbins, R. L. (1999). Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42, 128-138.

McGarry, J. D. & Foster, D. W. (1979). In support of the roles of malonyl-CoA and carnitine acyltransferase I in the regulation of hepatic fatty acid oxidation and ketogenesis. J Biol Chem 254, 8163-8168.

Medvedev, A. V., Robidoux, J., Bai, X., Cao, W. H., Floering, L. M., Daniel, K. W., & Collins, S. (2002). Regulation of the uncoupling protein-2 gene in INS-1 13-cells by oleic acid. Journal of Biological Chemistry 277, 42639-42644.

Medvedev, A. V., Snedden, S. K., Raimbault, S., Ricquier, D., & Collins, S. (2001). Transcriptional regulation of the mouse uncoupling protein-2 gene. Double E-box motif is required for peroxisome proliferator-activated receptor-gamma-dependent activation. J Biol Chem 276, 10817-10823.

Meissner, H. P. & Schmelz, H. (1974). Membrane potential of beta-cells in pancreatic islets. Pflugers Archiv European Journal of Physiology 351, 195-206.

Mertz, R. J., Worley, J. F., Spencer, B., Johnson, J. H., & Dukes, I. D. (1996). Activation of stimulus-secretion coupling in pancreatic beta-cells by specific products of glucose metabolism. Evidence for privileged signaling by glycolysis. J Biol Chem 271, 4838-4845.

Miki, T., Nagashima, K., & Seino, S. (1999). The structure and function of the ATP-sensitive K+ channel in insulin- secreting pancreatic beta-cells. J Mol.Endocrinol. 22, 113-123.

Miki, T., Nagashima, K., Tashiro, F., Kotake, K., Yoshitomi, H., Tamamoto, A., Gonoi, T., Iwanaga, T., Miyazaki, J., & Seino, S. (1998). Defective insulin secretion and enhanced insulin action in KATP channel- deficient mice. Proc Natl Acad Sci U.S.A 95, 10402-10406.

Miki, T., Tashiro, F., Iwanaga, T., Nagashima, K., Yoshitomi, H., Aihara, H., Nitta, Y., Gonoi, T., Inagaki, N., Miyazaki, J., & Seino, S. (1997). Abnormalities of pancreatic islets by targeted expression of a dominant- negative KATP channel. Proc Natl Acad Sci U.S.A 94, 11969-11973.

Millet, L., Vidal, H., Andreelli, F., Larrouy, D., Riou, J. P., Ricquier, D., Laville, M., & Langin, D. (1997). Increased uncoupling protein-2 and -3 mRNA expression during fasting in obese and lean humans. J.Clin.Invest 100, 2665-2670.

Misler, S., Barnett, D. W., Gillis, K. D., & Pressel, D. M. (1992). Electrophysiology of stimulus-secretion coupling in human beta-cells. Diabetes 41, 1221-1228.

Mitchell, P. (1979). Keilin's respiratory chain concept and its chemiosmotic consequences. Science 206, 1148-1159.

Mitrakou, A., Kelley, D., Mokan, M., Veneman, T., Pangburn, T., Reilly, J., & Gerich, J. (1992). Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N.Engl.J.Med. 326, 22-29.

Moller, D. E. (2001). New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414, 821-827.

Moore, G. B. T., Himms-Hagen, J., Harper, M. E., & Clapham, J. C. (2001). Overexpression of UCP-3 in skeletal muscle of mice results in increased expression of mitochondrial thioesterase mRNA. Biochemical and Biophysical Research Communications 283, 785-790.

Moreno-Sanchez, R. (1985). Contribution of the translocator of adenine nucleotides and the ATP synthase to

the control of oxidative phosphorylation and arsenylation in liver mitochondria. J Biol Chem 260, 12554-12560.

Murphy, M. P., Echtay, K. S., Blaikie, F. H., Asin-Cayuela, J., Cocheme, H. M., Green, K., Buckingham, J. A., Taylor, E. R., Hurrell, F., Hughes, G., Miwa, S., Cooper, C. E., Svistunenko, D. A., Smith, R. A., & Brand, M. D. (2003). Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria-targeted spin trap derived from alpha-phenyl-N-tert-butylnitrone. Journal of Biological Chemistry 278, 48534-48545.

Nakazaki, M., Kakei, M., Ishihara, H., Koriyama, N., Hashiguchi, H., Aso, K., Fukudome, M., Oka, Y., Yada, T., & Tei, C. (2002). Association of upregulated activity of K(ATP) channels with impaired insulin secretion in UCP1-expressing insulinoma cells. J.Physiol 540, 781-789.

National Diabetes Data Group (1995). Diabetes in America, 2nd ed. National Institutes of Health, Bethesda.

Nauck, M. A. (1998). Glucagon-like peptide 1 (GLP-1): A potent gut hormone with a possible therapeutic perspective. Acta Diabetologica 35, 117-129.

Nauck, M. A., Holst, J. J., & Willms, B. (1997a). Glucagon-like peptide 1 and its potential in the treatment of non-insulin-dependent diabetes mellitus. Horm Metabol Res 29, 411-416.

Nauck, M. A., Holst, J. J., Willms, B., & Schmiegel, W. (1997b). Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for Type 2-diabetes. Experimental and Clinical Endocrinology and Diabetes 105, 187-195.

Negre-Salvayre, A., Hirtz, C., Carrera, G., Cazenave, R., Troly, M., Salvayre, R., Penicaud, L., & Casteilla, L. (1997). A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J 11, 809-815.

Newgard, C. B. & McGarry, J. D. (1995). Metabolic coupling factors in pancreatic b-cell signal transduction. Annu Rev Biochem 64, 689-719.

Nicholls, D. G. (1974). Hamster brown-adipose-tissue mitochondria. The control of respiration and the proton electrochemical potential gradient by possible physiological effectors of the proton conductance of the inner membrane. Eur.J Biochem 49, 573-583.

Nicholls, D. G. (1979). Brown adipose tissue mitochondria. Biochim.Biophys.Acta 549, 1-29.

Nicholls, D. G. (2001). A history of UCP1. Biochemical Society Transactions 29, 751-755.

Nicholls, D. G. & Locke, R. M. (1984). Thermogenic mechanisms in brown fat. Physiol Rev 64, 1-64.

Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H. P., Giardino, I., & Brownlee, M. (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787-790.

Nordfors, L., Hoffstedt, J., Nyberg, B., Thorne, A., Arner, P., Schalling, M., & Lonnqvist, F. (1998). Reduced gene expression of UCP2 but not UCP3 in skeletal muscle of human obese subjects. Diabetologia 41, 935-939.

Notkins, A. L. (2002). Immunologic and genetic factors in type 1 diabetes. Journal of Biological Chemistry 277, 43545-43548.

Oberkofler, H., Liu, Y. M., Esterbauer, H., Hell, E., Krempler, F., & Patsch, W. (1998). Uncoupling protein-2 gene: reduced mRNA expression in intraperitoneal adipose tissue of obese humans. Diabetologia 41, 940-946.

Ohkubo, Y., Kishikawa, H., Araki, E., & et al. (1995). Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Research and Clinical Practise 28, 103-117.

Olefsky, J. M. (1981). Insulin resistance and insulin action: An in vitro and in vivo perspective. Diabetes 30, 148-161.

Ozkan, E. D. & Ueda, T. (1998). Glutamate transport and storage in synaptic vesicles. Jpn.J Pharmacol. 77, 1-10.

Palmieri, F., Bisaccia, F., Capobianco, L., Dolce, V., Fiermonte, G., Iacobazzi, V., Indiveri, C., & Palmieri, L. (1996). Mitochondrial metabolite transporters. Biochim.Biophys.Acta 1275, 127-132.

Paolisso, G., Tataranni, P. A., Foley, J. E., Bogardus, C., Howard, B. V., & Ravussin, E. (1995). A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38, 1213-1217.

Papa, S. & Skulachev, V. P. (1997). Reactive oxygen species, mitochondria, apoptosis and aging. Mol.Cell Biochem. 174, 305-319.

Park, K. S., Ciaraldi, T. P., Lindgren, K., Abrams-Carter, L., Mudaliar, S., Nikoulina, S. E., Tufari, S. R., Veerkamp, J. H., Vidal-Puig, A., & Henry, R. R. (1998). Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator- activated receptor-gamma. J Clin Endocrinol.Metab 83, 2830-2835.

Pasyk, E. A., Kang, Y., Huang, X., Cui, N., Sheu, L., & Gaisano, H. Y. (2004). Syntaxin-1A binds the nucleotide-binding folds of sulphonylurea receptor 1 to regulate the KATP channel. Journal of Biological Chemistry 279, 4234-4240.

Patane, G., Anello, M., Piro, S., Vigneri, R., Purrello, F., & Rabuazzo, A. M. (2002). Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition. Diabetes 51, 2749-2756.

Pavlou, K., Krey, N. S., & Steffee, W. P. (1989). Exercise as an adjunct to weight loss and maintenance in moderately obese subjects. American Journal of Clinical Nutrition 49, 1115-1123.

Pecqueur, C., Alves-Guerra, M. C., Gelly, C., Levi-Meyrueis, C., Couplan, E., Collins, S., Ricquier, D., Bouillaud, F., & Miroux, B. (2001). Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J Biol Chem 276, 8705-8712.

Pederson, R. A., Satkunarajah, M., McIntosh, C. H. S., Scrocchi, L. A., Flamez, D., Schuit, F., Drucker, D. J., & Wheeler, M. B. (1998). Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor (-/- ) mice. Diabetes 47, 1046-1052.

Perseghin, G., Petersen, K., & Shulman, G. I. (2003). Cellular mechanism of insulin resistance: potential links with inflammation. Int.J.Obes.Relat Metab Disord. 27 Suppl 3, S6-11.

Petersen, K. F. & Shulman, G. I. (2002). Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am.J.Cardiol. 90, 11G-18G.

Phillips, M. S., Liu, Q., Hammond, H. A., Dugan, V., Hey, P. J., Caskey, C. J., & Hess, J. F. (1996). Leptin receptor missense mutation in the fatty Zucker rat. Nat.Genet. 13, 18-19.

Pick, A., Clark, J., Kubstrup, C., Levisetti, M., Pugh, W., Bonner-Weir, S., & Polonsky, K. S. (1998). Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes 47, 358-364.

Poitout, V. & Robertson, R. P. (2002). Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity. Endocrinology 143, 339-342.

Porksen, N., Hollingdal, M., Juhl, C., Butler, P., Veldhuis, J. D., & Schmitz, O. (2002). Pulsatile insulin secretion: detection, regulation, and role in diabetes. Diabetes 51 Suppl 1, S245-S254.

Porte, D., Jr. (1991). Banting lecture 1990: B-cells in type II diabetes mellitus. Diabetes 40, 166-180.

Pralong, W.-F., Bartley, C., & Wollheim, C. B. (1990). Single islet b-cell stimulation by nutrients: Relationship between pyridine nucleotides, cytosolic Ca2+ and secretion. EMBO Journal 9, 53-60.

Prentki, M. & Corkey, B. E. (1996). Are the beta-cell signaling molecules malonyl-CoA and cystolic long- chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45, 273-283.

Prentki, M. & Matschinsky, F. M. (1987). Ca2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev 67, 1185-1248.

Prentki, M., Vischer, S., Glennon, M. C., Regazzi, R., Deeney, J. T., & Corkey, B. E. (1992). Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. Journal of Biological Chemistry 267, 5802-5810.

A-C

D-J

K-P

Q-Z